Primary total knee arthroplasty allogenic transfusion trends, length of stay, and complications: nationwide inpatient sample 2000-2009
- PMID: 25073900
- PMCID: PMC4254025
- DOI: 10.1016/j.arth.2014.06.018
Primary total knee arthroplasty allogenic transfusion trends, length of stay, and complications: nationwide inpatient sample 2000-2009
Abstract
Perioperative blood loss leading to blood transfusion continues to be an issue for total knee arthroplasty (TKA) patients. The US Nationwide Inpatient Sample (NIS) was used to determine annual trends in allogenic blood transfusion rates, and effects of transfusion on in-hospital mortality, length of stay (LOS), costs, discharge disposition, and complications of primary TKA patients. TKA patients between 2000 and 2009 were included (n = 4,544,999) and categorized as: (1) those who received a transfusion of allogenic blood, and (2) those who did not. Transfusion rates increased from 7.7% to 12.2%. For both transfused and not transfused groups, mortality rates and mean LOS declined, while total costs increased. Transfused patients were associated with adjusted odds ratios of in-hospital mortality (AOR 1.16; P = 0.184), 0.71 ± 0.01 days longer LOS (P < 0.0001), and incurred ($1777 ± 36; P < 0.0001) higher total costs per admission.
Keywords: blood loss; complications; nationwide inpatient sample; total knee arthroplasty; transfusion.
Copyright © 2014 Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Are Allogeneic Transfusions Decreasing in Total Knee Arthroplasty Patients? National Inpatient Sample 2009-2013.J Arthroplasty. 2018 Jun;33(6):1705-1712. doi: 10.1016/j.arth.2017.12.014. Epub 2017 Dec 21. J Arthroplasty. 2018. PMID: 29352682
-
Allogenic blood transfusion following total hip arthroplasty: results from the nationwide inpatient sample, 2000 to 2009.J Bone Joint Surg Am. 2014 Sep 17;96(18):e155. doi: 10.2106/JBJS.M.00825. J Bone Joint Surg Am. 2014. PMID: 25232085 Free PMC article.
-
Hospital Length of Stay following Primary Total Knee Arthroplasty: Data from the Nationwide Inpatient Sample Database.J Arthroplasty. 2015 Oct;30(10):1710-5. doi: 10.1016/j.arth.2015.05.003. Epub 2015 May 8. J Arthroplasty. 2015. PMID: 26009468
-
Do autologous blood transfusion systems reduce allogeneic blood transfusion in total knee arthroplasty?Knee Surg Sports Traumatol Arthrosc. 2017 Sep;25(9):2957-2966. doi: 10.1007/s00167-016-4116-z. Epub 2016 Apr 16. Knee Surg Sports Traumatol Arthrosc. 2017. PMID: 27085359 Review.
-
Factors associated with hospital stay length, discharge destination, and 30-day readmission rate after primary hip or knee arthroplasty: Retrospective Cohort Study.Orthop Traumatol Surg Res. 2019 Sep;105(5):949-955. doi: 10.1016/j.otsr.2019.04.012. Epub 2019 Jun 15. Orthop Traumatol Surg Res. 2019. PMID: 31208932 Review.
Cited by
-
Racial and Ethnic Disparities in Primary Total Knee Arthroplasty Outcomes: A Systematic Review and Meta-Analysis of Two Decades of Research.J Racial Ethn Health Disparities. 2024 Aug 19. doi: 10.1007/s40615-024-02105-x. Online ahead of print. J Racial Ethn Health Disparities. 2024. PMID: 39158831
-
Comparative analysis of acute blood loss anemia in robotic assisted vs. manual instrumented total knee arthroplasty.J Orthop. 2024 Apr 16;55:105-108. doi: 10.1016/j.jor.2024.04.013. eCollection 2024 Sep. J Orthop. 2024. PMID: 38681827
-
The Efficacy and Safety of Tranexamic Acid in Total Hip and Knee Arthroplasty: A Literature Review.HSS J. 2024 Feb;20(1):10-17. doi: 10.1177/15563316231208716. Epub 2023 Nov 2. HSS J. 2024. PMID: 38356752 Free PMC article.
-
Effect of recombinant human erythropoietin combined with iron sucrose on postoperative hemoglobin in patients undergoing artificial joint replacement.Sci Rep. 2023 Nov 2;13(1):18919. doi: 10.1038/s41598-023-41887-8. Sci Rep. 2023. PMID: 37919317 Free PMC article.
-
Effects of Thrombin-Based Hemostatic Agent in Total Knee Arthroplasty: Meta-Analysis.J Clin Med. 2023 Oct 20;12(20):6656. doi: 10.3390/jcm12206656. J Clin Med. 2023. PMID: 37892794 Free PMC article. Review.
References
-
- Sehat KR, Evans RL, Newman JH. Hidden blood loss following hip and knee arthroplasty. Correct management of blood loss should take hidden loss into account. J Bone Joint Surg Br. 2004 May;86(4):561–565. - PubMed
-
- Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am. 1999 Jan;81(1):2–10. - PubMed
-
- Bong MR, Patel V, Chang E, Issack PS, Hebert R, Di Cesare PE. Risks associated with blood transfusion after total knee arthroplasty. J Arthroplasty. 2004 Apr;19(3):281–287. - PubMed
-
- Rosencher N, Kerkkamp HE, Macheras G, et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion. 2003 Apr;43(4):459–469. - PubMed
-
- Surgenor DM, Wallace EL, Hao SH, Chapman RH. Collection and transfusion of blood in the United States, 1982-1988. N Engl J Med. 1990 Jun 7;322(23):1646–1651. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
